Circ_0005699 Expedites ox-LDL-Triggered Endothelial Cell Injury via Targeting miR-384/ASPH Axis

Cardiovasc Toxicol. 2024 Oct;24(10):1067-1076. doi: 10.1007/s12012-024-09889-8. Epub 2024 Jul 8.

Abstract

Atherosclerosis (AS) is an inflammatory disease with multiple causes. Multiple circular RNAs (circRNAs) are known to be involved in the pathogenesis of AS. To explore the function and mechanism of circ_0005699 in oxidative low-density lipoprotein (ox-LDL)-induced human umbilical vein endothelial cells (HUVECs) injury. Ox-LDL treatment restrained HUVECs viability, cell proliferation, and angiogenesis ability, and accelerated HUVECs apoptosis, inflammatory response, and oxidative stress. Circ_0005699 was up-regulated in the serum samples of AS patients and ox-LDL-induced HUVECs. Interference of circ_0005699 effectively rescued ox-LDL-induced injury in HUVECs. Additionally, miR-384 could bind to circ_0005699, and miR-384 depletion inverted the effects of circ_0005699 deficiency on ox-LDL-mediated HUVEC injury. Moreover, ASPH was a direct target of miR-384, and the enforced expression of ASPH overturned miR-384-induced effects on ox-LDL-induced HUVECs. Importantly, circ_0005699 regulated ASPH expression via sponging miR-384. Interference of circ_0005699 protected against ox-LDL-induced injury in HUVECs at least partly by regulating ASPH expression via acting as a miR-384 sponge.

Keywords: AS; ASPH; Circ_0005699; HUVECs; miR-384.

MeSH terms

  • Apoptosis* / drug effects
  • Atherosclerosis* / genetics
  • Atherosclerosis* / metabolism
  • Atherosclerosis* / pathology
  • Case-Control Studies
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Gene Expression Regulation
  • Human Umbilical Vein Endothelial Cells* / drug effects
  • Human Umbilical Vein Endothelial Cells* / metabolism
  • Human Umbilical Vein Endothelial Cells* / pathology
  • Humans
  • Inflammation Mediators / metabolism
  • Lipoproteins, LDL* / metabolism
  • Lipoproteins, LDL* / toxicity
  • MicroRNAs* / genetics
  • MicroRNAs* / metabolism
  • Neovascularization, Physiologic / drug effects
  • Oxidative Stress* / drug effects
  • RNA, Circular* / genetics
  • RNA, Circular* / metabolism
  • Signal Transduction*

Substances

  • oxidized low density lipoprotein
  • Lipoproteins, LDL
  • MicroRNAs
  • RNA, Circular
  • Inflammation Mediators